Why are employers slow to adopt site-neutral payments for infused therapies?

Many employers still pay hospital rates for infused therapies because few have implemented site-of-care programs, unlike Medicare, which adopted site-neutral reimbursement years ago. Barriers include data integration issues between medical and pharmacy benefits, operational constraints, and hospital leverage in network contracting, causing employers to miss potential savings.